Gotham Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,497
Closed -$247K 1343
2023
Q3
$247K Buy
+1,497
New +$194K 0.01% 1171
2020
Q1
Sell
-723
Closed -$454K 1090
2019
Q4
$454K Buy
+723
New +$354K 0.01% 841

Other funds holding CDLX

Gotham Asset Management's CDLX Position: Q4 2023 in Review

Gotham Asset Management sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 1,497 shares — an estimated $247K sold.

Gotham Asset Management first reported a position in CDLX in Q4 2019 and held it in 2 quarters. The position peaked at $454K in Q4 2019. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

  • Gotham Asset Management reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
  • Gotham Asset Management sold 1,497 Cardlytics shares in Q4 2023, an estimated $247K.
  • Gotham Asset Management first reported a position in Cardlytics in Q4 2019 and held it in 2 quarters.
  • Gotham Asset Management's Cardlytics position peaked at $454K in Q4 2019.
  • 124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.